Key result
HFmrEF shows similar 5-year survival to HFpEF in post-MI patients.
Why the study?
The long-term prognostic effect of inflammatory biomarkers in patients with myocardial infarction and heart failure with preserved and mid-range ejection fraction was not well established.
Do inflammatory biomarkers predict 5-year mortality in patients with MI and HFmrEF or HFpEF?
Cohort (n=135)
Do inflammatory biomarkers predict 5-year mortality in patients with MI and HFmrEF or HFpEF?
Answers are grounded in this paper and cite their sources.
Elevated levels of MMP-9, homocysteine, and platelets are significant predictors of 5-year mortality in patients with MI and HFmrEF or HFpEF following PCI.
Aim. To evaluate the effect of biomarkers of inflammation on the long-term prognosis in patients with myocardial infarction (MI) and heart failure (HF) with preserved and mid-range ejection fraction according to a registry of percutaneous coronary interventions (PCI). Material and methods . A total of 135 patients with MI included in the PCI registry in 2012-2013 were examined. Group 1 included 89 patients with HF with mid-range ejection fraction (HFmrEF) — 40-49%; group 2 included 46 patients with HF with preserved ejection fraction (HFpEF) — ≥50%. Biomarkers of inflammation were determined at admission to the hospital, after 12 and 60 months. Results . Eighteen people died during the follow-up period. The survival rate of patients in the compared groups after 60 months did not differ (group 1 — 85,0%; group 2 — 89,1%, p=0,492). Mortality predictors were the platelet count (HR, 1,011; 95% CI, 1,003-1,019; p=0,010), homocysteine level (HR 1,172; 95% CI, 1,008-1,364; p=0,040), MMP-9 >249 ng/ml (HR, 7,052; 95% CI, 1,346-36,950; p=0,021). In both groups there was a decrease in survival in patients with high levels of MMP-9 (>249 ng/ml). In group 1, mortality was higher among patients with platelet count >245*10 9 /l. In both groups the levels of inflammatory markers exceeded the standard values for the entire period of follow-up. The dynamics of NT-proBNP, hs-CRP, TNF-α and homocysteine had a unidirectional pattern, in particular, a decrease in parameters after 12 months, followed by their increase after 60 months. Conclusion . Levels of MMP-9, homocysteine, and platelets were the factors that influenced 5-year survival in the general group of patients after MI and PCI. In the group with HFmrEF, MMP-9 and platelets had a negative impact on the prognosis. In patients with HFpEF, reduced survival was associated only with high levels of MMP-9. The dynamics of markers of systemic inflammatory response and NT-proBNP indicates the prolonged inflammatory process in both groups of patients, persisting for 5 years after MI.
No takes yet. Share an insight, caveat, or question.
Musikhina et al. (2020) conducted a cohort in Myocardial infarction and heart failure with preserved and mid-range ejection fraction (n=135). Heart failure with mid-range ejection fraction (HFmrEF) vs. Heart failure with preserved ejection fraction (HFpEF) was evaluated on Survival at 60 months (p=0.492). Heart failure with mid-range ejection fraction had similar 60-month survival compared to preserved ejection fraction in patients post-myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: